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The purpose of these studies was to test the hypothesis that
Randall’s plaque develops in unique anatomical sites of the
kidney and their formation is conditioned by specific
stone-forming pathophysiologies. We performed
intraoperative papillary biopsies from kidneys of
idiopathic-calcium oxalate (CaOx), intestinal bypass for
obesity, brushite (BR) and cystine stone formers (SF) during
percutaneous nephrolithotomy. Tissues were examined by
infrared analysis and light and electron microscopy. Our
analysis revealed a distinct pattern of mineral deposition and
papillary pathology for each type of SF. CaOx SF had
interstitial apatite crystals beginning at thin loops of Henle.
These deposits termed Randall’s plaque are thought to serve
as sites for stone attachment. No tubular injury was noted.
Intestinal bypass patients possessed intraluminal apatite
deposits in inner medullary collecting ducts (IMCD) with
associated cell injury. BR SF showed the most severe form of
cortical and medullary changes with sites of Randall’s plaque,
and yellowish intraluminal deposits of apatite in IMCD.
Cystine SF had plugging of ducts of Bellini with cystine
crystals and apatite deposits in IMCD and loops of Henle.
Intratubular sites of crystalline deposits were always
associated to adjacent regions of interstitial fibrosis. The
metabolic, anatomic, and surgical pathologic findings in four
distinct groups of SF clearly show that ‘the histology of the
renal papilla from a stone former, is particular to the clinical
setting’. We believe our approach to studying stone disease
will provide insights into the pathogenesis of stone
formation for each type of SF that will lead to improved
clinical treatment.
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PLAQUE IN IDIOPATHIC CALCIUM OXALATE STONE FORMERS
Patients who form calcium oxalate (CaOx) renal stones
without any systemic disorder apart from familial (so-called
idiopathic) hypercalciuria (IH) represent the most common
kind of kidney stone patient and are often referred to as
‘idiopathic calcium oxalate SF’ (ICSF). It is among these
patients that research on Randall’s plaque has led to new
discoveries and the reasonable beginnings of a pathogenetic
scheme that connects physiological abnormalities and a
characteristic renal histopathology to the clinical manifesta-
tion of stone formation. Among the systemic disorders that
must be excluded, we include primary hyperparathyroidism,
sarcoidosis, hyperthyroidism, glucocorticoid excess, renal
tubular acidosis (RTA), hyperoxaluric states of all varieties,
patients whose stones contain above 50% calcium phosphate,
and of course patients with non-calcium stones of any kind.
These criteria define the phenotype for which this portion of
the review is valid. Whether or not the pathogenetic elements
we describe here are germane to other kinds of stone formers
(SF) remain untested.
CaOx stones grow over interstitial plaque
In ICSF, many stones are found attached (Figure 1a and b) to
the renal papillae.1 The attachment site is over a whitish
deposit called Randall’s plaque (Figure 1). When stones are
removed, the plaque undersurface is easily seen (Figure 1c
and d). In our recent survey of 24 kidneys in 23 ICSF, we
found plaque in 100% of cases and in 48% (11 patients)
stones were found attached to areas of plaque.1 Within these
11 people, 49 papillae had attached stones. In the 24 kidneys,
we inspected 172 papillae and found plaque on 156 (91%).
Our attachment rates are likely to be underestimates. We
made our observations during percutaneous nephrolitho-
tomy (PNL). Access to the renal interior is via a papillum and
attached stones on that papillum may easily be dislodged by
the procedure itself and the papillum of access cannot be
reliably examined. Patients who require PNL are those with
the largest target stones (generally above 2 cm) and these
large stones frequently are unattached. For those stones in
ICSF that are attached, attachment to plaque has thus far
been the invariable rule without an exception. For those
stones found unattached, we cannot as yet say where they
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originated. Evidence from stone morphology has suggested a
papillary origin for unattached stones.2,3 This remains an
open investigative area.
If indeed CaOx stones require plaque to anchor them and
permit development into clinically relevant stones, we should
expect that patients with more stones would have a higher
fraction of their papillae covered by plaque. This is indeed the
case (Figure 2a).4 The relationship holds even after adjust-
ment for the number of years of stone formation (Figure 2b).
This kind of correlation does not tell us whether plaque
fosters stones, or the converse, but given our histopathology
and gross findings, the former is overwhelmingly the more
reasonable alternative.
Characteristics of interstitial plaque
The earliest and most minimal deposits of plaque are in the
basement membrane of the thin loops of Henle (Figure 3a).5
This location is invariably involved with plaque and is the
only location where plaque can be found in isolation. In
many regions, plaque becomes very dense around thin loops
and appears to spread from the loops into the surrounding
interstitial space (Figure 3b). Often, as in this illustration, one
finds plaque migrating down the papillary tip towards the
urothelium. Plaque is never found in the lumens of tubules
or vessels, or within epithelial cells; it is uniquely located in
the basement membranes and the interstitium. Therefore, as
expected, the renal epithelial cells invariably appear normal,
as does the cellular interstitium.
Within the basement membranes, plaque consists of
individual laminated particles in which zones of crystal and
organic matrix overlay each other in a tree-ring pattern
(Figure 3c and d). In the interstitium, the particles fuse to
form a syncytium of crystal islands in an organic sea (Figure
3e and f). At no time have we found crystals not coated by an
organic layer. This means it is most unlikely that CaOx stones
grow over plaque crystals themselves. Rather, CaOx must
grow over the organic material that invariably coats plaque
crystals.
Relationship of plaque to the urothelium
Not only does the organic layer intervene between CaOx and
plaque crystals, the urothelium is present as well. Plaque
without stones appears at surgery almost always covered by a
shiny, intact urothelial layer. Moreover, the urothelial layer is
coated by a complex glycoprotein mixture that includes a
variety of glycosaminoglycans.6 This means CaOx must
somehow localize itself to plaque areas despite at least two
intervening barriers, urothelium and its organic coating. This
implies some complex biology, perhaps induced by plaque
and affecting urothelium, about which nothing is presently
known. In essence, the events involved in the transition from
plaque to plaque with stone remain, at this time, unclear.
Nature of the plaque crystal
Using high-resolution Fourier transform infrared micro-
spectroscopy (FTIR) and electron diffraction, the crystal
component of plaque particles is calcium phosphate (CaP) in
the form of apatite.5 The apatite is seemingly identical to that
found in bone. Given that the apatite microparticles are
forming in the type IV collagen of basement membranes and
type I in the interstitial space, the process is most closely
analogous to that of bone formation. Whether this analogy
will be fruitful in terms of new research remains to be tested.
An example of what may be a similar process is coronary
artery calcification, in which cell transformation to osteoblast
character has been documented.7 Although CaOx crystals can
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Figure 1 | Digital photographs obtained with an endoscope at the
time of PNL showing calcium oxalate monohydrate stones
attached to the renal papilla of two different idiopathic CaOx SF.
The compound papillae in (a) and (b) show sites of irregular whitish
suburothelial material termed Randall’s plaque (single arrows) that
are associated with two small stones (asterisks). Numerous stones
attached to a papilla tip (c) and after these stones were removed (d),
and they appear to have been attached to sites of Randall’s plaque
(single arrows).
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Figure 2 | (a) Number of stones vs log transformed mean plaque
surface area. Nonparametric ellipse of containment includes two
standard deviations. (b) Number of stones vs multivariate regression
equation from general linear model, including stone disease duration
and plaque surface. Plaque time score¼ 1.788þ 1.386 log 10 mean
plaque surface areaþ 0.082 time. Reprinted with permission from
the Journal of Urology.4
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be found in tissues of animals induced to form stones via
oxalate loading, that crystal is never present in interstitial
plaque. In fact, thus far, in our studies of a range of human
SF, we have never found CaOx in the renal interstitium.5,8,9
Nature of plaque matrix
To date, we have identified only osteopontin among the
constituents of matrix (Figure 4a–c).10 The osteopontin
appears to localize preferentially at the matrix–apatite crystal
interface. This is not surprising given the well-known affinity
of osteopontin for calcium crystal surfaces.11 The role of
osteopontin in plaque formation is unknown. Osteopontin
can inhibit nucleation, growth, and aggregation of calcium
phosphate crystals, and if anchored to collagen or crystal
surfaces could also serve as a nucleating site for new crystals.
Obviously, there are many other molecules in the organic
matrix beside osteopontin that remain to be discovered. This
is an important area of potential new research.
Mechanism of plaque formation
Using 24-h urine collections from ICSF and normal subjects,
the fraction of papillary surface covered by plaque varies with
24-h urine calcium excretion and inversely with urine volume
and pH (Figure 5).12 The wide range of urine calcium
excretions reflects the fact that a majority of ICSF have IH.
The correlation of plaque with hypercalciuria suggests some
common and perhaps causal connections. IH is generally
thought to arise from increased tissue vitamin D response.13
Serum 1,25-dihydroxy vitamin D levels are above normal as is
intestinal calcium absorption. Linkages between IH and
plaque could therefore be via the increase of calcium
movement from blood to urine or via vitamin D response
of renal cells in the medulla and papillum. Because there is no
animal model of human plaque thus far, research in this area
is very incomplete.
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Figure 3 | Histologic images showing sites of Randall’s plaque
and its progression. (a) The initial site and size of calcium deposits in
the papillary tissue of a CaOx patient as seen by light microscopy,
while (c) and (d) show these same structures by transmission electron
microscopy. Sites of crystalline material (arrows) are first noted in the
basement membranes of the thin loops of Henle. The individual
deposits are as small as (c) 50 nm and (d) grow into multi-laminated
spheres of alternating light and electron dense rings. Extensive
accumulation of crystalline deposits occur around the loops of Henle
and spread into the nearby interstitial space (b) extending to the
urothelial lining of the urinary space. Individual deposits accumulate
in the interstitium forming an island of mineral encased in a matrix
material (e). These islands can completely surround individual tubules
(f). Original magnification, (a)  900; (b)  500; (c)  25 000; (d)
 70 000; (e)  13 000; (f)  10 000. Panels (c and e) reprinted with
permission from the Kidney International.10
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Figure 4 | Immunoelectron microscopic localization of osteopon-
tin to the basement membrane of loops of Henle and the
medullary interstitium. (a) A high magnification TEM showing
immunogold label indicating osteopontin localization within single
crystals that is found at the interface of the crystalline material and
the organic layer. This particle was located in the basement
membrane of a loop of Henle. (b and c) Immunogold label (arrows)
localization of osteopontin within crystalline deposits that are
coalescing to form regions of interstitial plaque. Original magnifica-
tion, (a)  50 000; (b)  35 000; (c)  14 000. Reprinted with
permission from the Kidney International.10
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Given that plaque forms in the thin loops of Henle,
one is not surprised that its abundance increases with
water conservation. Obvious candidates for a link between
water conservation and plaque would be interstitial
calcium concentration or even osmolality itself. This is an
unexplored area of research. In producing acid urine, inner
medullary epithelial cells could concomitantly increase
interstitial fluid pH. Since apatite crystals form preferentially
in alkaline media, this might be an explanation for the link
between urine pH and plaque abundance. Until an animal
model of plaque can be obtained, this matter cannot be fully
explored.
CaOx SF WITH OBESITY BYPASS SURGERY LACK PLAQUE
One clue to pathogenesis is the absence of plaque in this type
of SF. Their urine is acidic14 but their urine volumes are high,
and urine calcium excretion rates are in the normal range.
Elevated urine oxalate is the putative cause of their stones,
and no attached stones were ever observed on any papillum.
This pattern supports the notion that high urine calcium or
IH itself, or perhaps urine osmotic concentration, are more
central to plaque formation than an acid urine pH. Of
interest, these patients form intratubular crystal masses in
their inner medullary collecting ducts (IMCD) (Figure 6a and
b). IMCD cells are injured in regions of deposits and the
surrounding interstitium is inflamed and fibrotic. Such cell
injury and interstitial reaction is never found in ICSF.
Although stones are CaOx with little or no CaP, and although
urine pH is low, these IMCD deposits are apatite. Apatite is
unstable at the average urine pH of 5.57 found in these
patients, meaning that local tubule pH must depart from that
of the bulk phase urine. These patients are an instructive
natural experiment and illustrate the range of pathology one
can encounter in CaOx SF.
PLAQUE IN BRUSHITE SF
Like ICSF, Brushite (BR) SF have IH and also have plaque.8
Stones are attached to papillae, but as extensions into the
lumen of long IMCD and Bellini duct (BD) apatite plugs, and
not as overgrowths on interstitial plaque. These IMCD and
BD plugs were described by Randall15 as his Type 2 form of
plaque and present themselves as yellow elongate, distinct
suburothelial deposits easily distinguished from white inter-
stitial plaque with its vague serpiginous borders (Figure 6c
and d). Like bypass SF, BR SF have cell injury and interstitial
reaction in regions of IMCD deposits (Figure 6c and d), but
the process is far more severe. Gross papillary morphology is
abnormal with retraction and pitting deformities (Figure 6c).
Involved IMCD are massively dilated with extensive cell
necrosis and denuding of basement membranes. Although
the stones are BR (calcium mono-hydrogen phosphate), the
deposits are apatite, an entirely different crystal.
We did not observe stones growing attached to interstitial
plaque regions. In part, this could reflect the massive volume
of BR stones that would interfere with detection of tiny
attached stones. Likewise, the deformity of the papillae could
affect our ability to visualize such stones. It is our impression,
however, that they are not present.
Our current formulation is that BR SF begins often
as CaOx SF because many patients initially form such stones
and BR SF has IH about as often as do CaOx SF.
What distinguishes patients with CaP in stones from those
with only CaOx is mainly higher urine pH.16 Because
of IH and perhaps efficient water conservation, BR SF may
form plaque when producing CaOx stones. As their urine pH
rises, for reasons we do not as yet know, CaP becomes
the predominant stone mineral and stones attached to
interstitial plaque become rare enough that we have not as
yet been able to document them. An alternative formulation
is that IH leads to plaque in BR SF but BR stones simply do
not form over plaque the way CaOx stones apparently do. It
is clear that BR SF, like bypass SF, offer unique research
opportunities.
PLAQUE IN CYSTINE SF AND NON-STONE-FORMING
SUBJECTS
Patients with cystinuria form cystine stones. Biopsy of
their papillae reveals plugging of BD with masses of cystine
crystals (Figure 6e).9 This is expected as BD contains the
same final urine that clearly produces cystine crystals and
stones. Unexpectedly, they form apatite deposits in
their IMCD and even their thin loops of Henle (Figure 6f).
Mechanisms responsible for apatite deposits could
include alkali loading in treatment of cystine stones, or
obstruction of IMCD by BD plugs of cystine with resulting
acidification defects that permit apatite crystallization.
Interstitial plaque is present at the abundances found in
non-stone-forming people. Cystine stones grow attached
to BD cystine deposits and are also found frequently free in
the renal pelvis. They are not attached to the small amounts
of plaque.
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Figure 5 | Fractional plaque coverage per papillium varies
inversely with urine volume (upper left panel) among SF (closed
circle) and non-stone-forming control subjects (open circle).
Plaque coverage varies with urine calcium excretion (upper middle
panel) and is inverse to urine pH (upper right panel). A composite
multivariate score using urine volume and calcium excretion (lower
left panel) and one that includes urine pH as well (lower right panel)
strongly correlate with plaque coverage. Reprinted with permission
from the Kidney International.12
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AN ATTEMPT AT SYNTHESIS AT THE PRESENT TIME
Somehow, perhaps because of IH, plaque forms and migrates
beneath the urothelium. Urine crystallization potential is
certainly increased by IH and promotes CaOx overgrowth to
produce routine ICSF patients. In some of these patients,
IMCD lumen pH increases and permits high calcium
concentrations from IH and water extraction to express
themselves in the formation of apatite crystals that damage
cells. Mechanisms for such an increase could include:
repeated obstruction from stones, even mild chronic urinary
obstruction, protracted use of alkali as potassium or calcium
salts, renal damage from extracorporeal shock wave litho-
tripsy, and initial formation of even the most microscopic
CaOx crystals that cannot produce any clinical manifestations
but could attack apical cell membranes and disorder pH
regulation. Such a mechanism could possibly engender
apatite deposits in IMCD of bypass patients. As well, apical
membrane attack by cystine crystals or the necessary but
extensive use of potassium alkali to control cystine solubility,
could lead to the IMCD apatite deposits we have found in
such patients.
The fact that plaque forms in cystinuria and normal
subjects suggests that even normal amounts of calcium
movement through the nephron are sufficient for plaque
production. Perhaps when urine volumes are habitually low,
it is fostered to a greater extent. Randall found plaque within
kidneys from unselected autopsy cases, most of who were not
SF. The examples of cystinuria and normal people point away
from specialized effects of IH and toward plaque as a part of
normal renal mineral handling that is exaggerated in SF
because of high rates of calcium movement through the
nephron. In fact, a few of our ICSF had relatively normal
urine calcium (Figure 5) and correspondingly low plaque
abundance. Lacking an animal model, we must be content
with what we can learn from patients.
Within the admittedly narrow confines of what we know,
at least one treatment stands out as having a great potential
for reducing the formation of plaque. Plaque surface area falls
as urine volume increases, and such treatment offers no
apparent disadvantages or risks. Whether thiazide, which
lowers urine calcium, would lower plaque abundance is far
less easy to predict. So, as clinicians, we are endorsing from
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Figure 6 | Endoscopic and histologic images of crystal deposition in human papillary tissue from three different types of SF. (a) An
example of a papilla from an intestinal bypass stone former that was video recorded at the time of PNL. Distinct sites of Randall’s plaque
material are not found on this papilla; instead, several nodular appearing structures (arrowheads) were noted near the openings of ducts of
Bellini. (b) A low magnification light microscopic image of a papillary biopsy specimen also from an intestinal bypass stone former. Crystal
deposition was only found in the lumens of a few collecting ducts as far down as the ducts of Bellini (asterisk). Note dilated collecting ducts
(arrows) with cast material and regions of fibrosis around crystal deposit-filled collecting ducts. (c) An example of a papilla from a BR patient
that was video recorded at the time of PNL. This papilla shows the irregular white areas of crystalline deposits (arrows) beneath the urothelium
that was described for CaOx patients. In addition, the papilla from BR patients possesses sites of a yellowish crystalline deposit at the openings
of ducts of Bellini (asterisk). Note the enlargement of the opening of a duct of Bellini that is filled with crystalline material (asterisk) seen as a
depression or ‘pit’ on the papilla. A large pit (arrowheads) is seen along the side of this papilla and does not appear to be associated with a duct
of Bellini. (d) A low-magnification light-microscopic image of a papillary biopsy specimen from a BR patient showing an enormous amount of
Yasue positive material within an IMCD (arrows). This crystalline material is seen protruding from the opening of the duct of Bellini (asterisk). In
addition, Yasue positive material is seen in the interstitium of the renal papilla surrounding thin loops of Henle (double arrows) as we have
previous described for CaOx SF. (e) The papillary morphology by endoscopic examination of a cystine stone former at the time of PNL. Papilla
from cystine SF varied from normal to flattened with greatly enlarged openings of the ducts of Bellini with protruding plugs of crystalline
material (double arrow). Small sites of suburothelial white plaque (not shown), termed Randall’s plaque, were noted. The insert in (e) shows a
plug of cystine at the end of a duct of Bellini. The papillary histopathology of the cystine patients varied from normal to regions of plugging,
dilation, and injury of IMCD (arrows, f). Intraluminal plugging with crystals was noted in thin loops of Henle (insert, f). Original magnification,
(b)  90; (d)  100; (f)  150. Panels (a and b) reprinted with permission from JCI.5 while panels (c and d) were reprinted with permission from
Kidney International.8
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the vantage point of our newest investigations, what our
forebears endorsed long before us as a stable underpinning
for the treatment of virtually any stone-forming patient.
LIMITATIONS OF CONTEMPORARY ANIMAL MODELS
Throughout we have alluded to our lack of an animal model
for the study of plaque. This is despite at least eight models of
hypercalciuria in rodents. By inbreeding, a rat strain has been
established with a 10-fold increase of urine calcium above
normal. Although the rats are a close simulacrum of human
IH, driven by high vitamin D receptor expression, and
produce both CaP and CaOx stones, depending on diet, and
in this way strongly resemble human SF, they produce no
plaque and never form attached renal stones.17 The ob/ob
mouse model of obesity and diabetes is known to have 1,25-
vitamin D excess18 that has been ascribed to leptin deficiency.
Despite hypercalciuria, neither plaque nor stones have been
described. There are three mouse models of Dent’s disease,19
of which one is persistently hypercalciuric, with hypercal-
ciuria ascribed to high 1,25-vitamin D levels. Plaque has not
been described in these mice. Our inspection of the published
figures shows intratubular deposits in medullary collecting
ducts with peritubular interstitial fibrosis. These changes
were reduced by treatment with citrate. In proximal tubule
cells, tiny calcium deposits appear to follow basolateral
infoldings. Hypercalciuria due to high 1,25-vitamin D levels
has been described in a klotho gene knockout mouse.20
Plaque was not found despite obvious hypercalciuria and
hypercalcemia. The authors report deposition of calcium in
the kidneys. Published pictures do not permit independent
evaluation by us as to localization. Hypercalciuria occurs in
mice with TRPV5 gene knockout, but no mention is made of
renal calcification. Mice with knockout of NaPi IIa, a
sodium-phosphate co-transporter, develop renal phosphate
wasting, hypercalciuria, hypercalcemia, elevated 1,25 vitamin
D levels, and renal calcification. The calcifications are
intratubular across the entire nephron, but no plaque has
been described. A mouse model of Cav1 knockout develops
hypercalciuria and urinary tract calculi, but no renal
calcifications.19 Knockout of aldose reductase causes hyper-
calciuria, but there is no description of renal calcification.19
Most recently, a mouse NHERF-1 knockout model has been
described, with increased urinary calcium excretion and
elevated 1,25-vitamin D levels.19 Calcifications are present in
the renal papillae of these mice, but further study will be
needed to determine if these calcifications resemble plaque
seen in human SF.
This large panel of hypercalciuric animals studied by well-
established laboratories suggests that plaque formation may
be a very specialized event not necessarily unique to humans,
but dependent upon more than simply hypercalciuria. It
could be that water conservation is imperfect in these
animals; the hypercalciuric rats are described as polyuric, as
are the aldose reductase knockout mice, the CLC5 knockout
mice, and the TRPV5 knockout mice.19 Alternatively, plaque
formation may require more time than is available in the
rodent experiments described thus far.
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